Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Amarin Corporation PLC

AMRN ✗ NOT COMPLIANT ☆ Track — members

Nasdaq · Healthcare · Biotechnology & Medical Research ·

USA Micro Cap Analyst: SELL

Last Close

$14.07

▼ -0.57%

Market Cap $297.20M · Vol 19.18K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$297.20M

Micro Cap

Div Yield

N/A

EPS Growth

-275.00%

YoY

RSI (14)

57.83

Momentum

Beta

0.76

vs Market

52W High

$20.85

32.52% below

52W Low

$13.22

6.43% above

Volume

19.18K

Avg 14.94K

P/B

0.63

Price-to-book

ROE

N/A

Return on equity

Free Float

62.81%

Public shares

Shariah Compliance8 STANDARDS

✗ Amarin Corporation PLC (AMRN) stock is currently not Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See which standards it fails, the exact ratios behind the verdict, and halal alternatives. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does AMRN pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-2.02%

-2.09%

-4.80%

-4.55%

YTD

+0.82%

-6.45%

-33.00%

-87.02%

Financials & Valuation

TTM · Annual

Total Revenue	$213.65M
Net Income	$-38,798,000.00
Revenue Growth (YoY)	-41.97%
Gross Margin	56.57%
Operating Margin	-6.53%
Net Profit Margin	-18.16%
ROE	N/A
ROA · ROIC	-5.32% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	1.36
P/B	0.63
P/FCF	43.04
EPS Growth	-275.00%
Outstanding Shares	422.46M

Technical Indicators

50-Day SMA	$14.76
200-Day SMA	$14.91
RSI (14)	57.83
Beta	0.76
52-Week High	$20.85
52-Week Low	$13.22

Volume Today	19.18K
Avg Daily Volume (30D)	14.94K
Relative Volume	1.28x
Volatility (10D)	15.72
Volatility (30D)	23.03
Free Float	62.81%

Analyst Consensus

SELL

Current Price $14.07

Mean Target N/A

52W Low$13.22 52W High$20.85

Current

Target

$13.22 $20.85

Current Analyst target

· 1 analysts

Identifiers

ExchangeNasdaq

FIGIBBG001SD42R0

ISINUS0231114044

CountryIreland

Sub-IndustryBio Therapeutic Drugs

Earnings DateOct 27, 2026

TypeStocks

Instrument TypeADR American Depositary Receipt

Similar Halal Stocks

2359.HK WuXi AppTec Co Ltd -2.85% ARGX.BR argenx SE -3.21% ARGX argenx SE -0.66% INSM Insmed Inc -2.05% 2269.HK WuXi Biologics (Cayman) Inc -1.27%

Company Profile

Amarin Corporation PLC is a pharmaceutical company. The Company is focused on the commercialization and development of therapeutics to improve cardiovascular (CV), health and reduce CV risk. The Company operates through the development and commercialization of VASCEPA. Its lead product, Vascepa (icosapent ethyl) capsule is used as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. This indication for Vascepa, known as the MARINE indication, is based primarily on the results from the MARINE study of Vascepa in this approved patient population. The Company sells Vascepa principally to wholesalers, as well as selected regional wholesalers and specialty pharmacy providers, or collectively, its distributors, which in turn resell Vascepa to retail pharmacies for resale to patients and healthcare providers.